From: Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients
HR [95%CI]
p-value
IL-6 at Day 0 (log)
2.20 [1.58–3.05]
 < 0.001
SOFA
1.09 [0.90–1.31]
0.40
Time between symptom onset
and dosage (days)
1.09 [1.00–1.19]
0.04